Terns Pharmaceuticals, Inc. Quarterly Earnings Per Share, Basic in USD/shares from Q3 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Terns Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q3 2021 to Q3 2024.
  • Terns Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.28 USD/shares, a 33.3% increase year-over-year.
  • Terns Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -1.18 USD/shares, a 6.31% decline year-over-year.
  • Terns Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2023 was -1.27 USD/shares, a 24% increase from 2022.
  • Terns Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -1.67 USD/shares, a 24.4% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$1 $0 +$0.14 +33.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$1 $0 $0 -24% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 -$1 $0 +$0.01 +3.23% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$1 $0 $0 -123% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 -$1 $0 +$0.02 +4.55% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$1 $0 +$0.30 +54.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 -$1 $0 +$0.24 +43.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$2 $0 Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 $0 +$0.03 +6.38% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$1 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$1 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.